Hereditary PC with pathogenic BRCA2 variants exhibits bi‐allelic BRCA2 inactivation by germline mutation and somatic loss of heterozygosity (LOH), while PC with somatic BRCA2 alterations exhibits two‐hit alterations in the tumor. Here, BRCA2 is linked to neoplasm.